2,4,5-Trifluorophenylacetic Acid CAS 209995-38-0 Kemurnian ≥99,5% (GC) Sitagliptin Fosfat Monohydrate Intermediate

Katrangan singkat:

Jeneng Kimia: 2,4,5-Trifluorophenylacetic Acid

CAS: 209995-38-0

Kemurnian: ≥99,5% (GC)

Penampilan: Bubuk Putih nganti Putih

Intermediate of Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9) kanggo perawatan diabetes tipe 2

Kualitas Tinggi, Produksi Komersial

E-Mail: alvin@ruifuchem.com

Kirimi email kanggo kita

Detail Produk

Produk sing gegandhengan

Tag produk

katrangan:

Pasokan Sitagliptin Phosphate Monohydrate Related Intermediate:
Sitagliptin API CAS 486460-32-6
Sitagliptin Phosphate Monohydrate API CAS 654671-77-9
2,4,5-Asam Trifluorofenilasetat CAS 209995-38-0
Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyric Acid CAS 486460-00-8
Sitagliptin Triazole Hydrochloride CAS 762240-92-6
Sitagliptin Phosphate Monohydrate Intermediate CAS 486460-21-3

Sifat Kimia:

Jeneng Kimia	2,4,5-Asam Trifluorofenilasetat
Nomer CAS	209995-38-0
Nomer CAT	RF-PI1191
Status Simpenan	Ing Simpenan, Skala Produksi Nganti Ton
Formula Molekul	C8H5F3O2
Bobot Molekul	190.12
Titik Lebur	121,0 kanggo 125,0 ℃
Kelarutan	Larut ing Metanol
Merk	Kimia Ruifu

Spesifikasi:

Item	Spesifikasi
Penampilan	Bubuk Putih nganti Putih
Kemurnian / Metode Analisis	≥99,5% (GC)
Kelembapan (KF)	≤0,50%
Sisa ing Ignition	≤0,50%
Total Impurities	≤0,50%
Standar Tes	Standar Perusahaan
Panggunaan	Intermediate saka Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9)

Paket & Panyimpenan:

Paket: Botol, tas Aluminium foil, 25kg / Drum Karton, utawa miturut kabutuhan pelanggan.

Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya lan Kelembapan.

Kaluwihan:

FAQ:

Aplikasi:

2,4,5-Trifluorophenylacetic Acid (CAS: 209995-38-0) minangka perantara saka Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9).Sitagliptin Phosphate (STG) digunakake kanggo nambani DM tipe 2 amarga nambah kontrol glikemik kanthi nambah tingkat hormon incretin aktif, GLP-1 (peptida-1) lan GIP (glucose-dependent insulinotropic peptide).Aktivasi incretin kasebut ing sel β-pankreas nyebabake paningkatan tingkat siklik adenosin monofosfat (cAMP) lan kalsium intraselular, kanthi sekresi insulin gumantung glukosa sabanjure (2).Obat hipoglikemik iki kalebu kelas anyar sing diarani inhibitor dipeptidyl peptidase IV.STG disetujoni dening FDA ing 2006.